Susquehanna International Group, LLP Century Therapeutics, Inc. Transaction History

Susquehanna International Group, LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$1.28 - $3.32 $28,965 - $75,128	22,629 New	22,629 $75,000
Q1 2023 May 16, 2023	BUY	$3.4 - $5.11 $36,539 - $54,917	10,747 New	10,747 $37,000
Q2 2022 Aug 15, 2022	BUY	$7.96 - $12.43 $112,649 - $175,909	14,152 New	14,152 $119,000
Q3 2021 Nov 15, 2021	SELL	$20.8 - $31.93 $478,420 - $734,421	-23,001 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$22.45 - $29.34 $516,372 - $674,849	23,001 New	23,001 $675,000

36.9M

8.7K

10.2K

Ticker IPSC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,881,800
Market Cap $79.5M
Description
Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 fo...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.